{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:05:03Z","timestamp":1789571103674,"version":"build-2803163510"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stratification of well-appearing febrile infants into a low-risk category for invasive bacterial infections (IBI) is critical to optimizing patient care. Procalcitonin (PCT), a biomarker associated with bacterial infection, was included in the 2019 Pediatric Emergency Care Applied Research Network (PECARN) clinical prediction rule to identify febrile infants 60\u00a0days and younger at low risk for serious bacterial infection. That same year, we incorporated a modified PECARN febrile infant prediction rule into our existing febrile infant algorithm. The primary objective of the study was to evaluate the effect of the modified PECARN prediction rule on rate of lumbar puncture (LP), hospital admissions, and 30-day readmissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified febrile infants 3 to 90\u00a0days evaluated in our emergency department from November 2017 through April 2022. The pre-implementation period was from November 2017 to June 2019. The modified PECARN rule was incorporated into the clinical care process model between July 2019 and August 2019. The post-implementation period was September 2019 through April 2022. The primary outcomes were LP rate and hospital admissions. The primary process metric was PCT obtainment. The balancing metric was 30-day readmissions. Between group comparisons were performed with Chi square tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1520 febrile infants were included in the analysis, 662 in the pre-implementation period, and 858 in the post-implementation period. Lumbar puncture rate and hospital admissions decreased from 45.8% to 31.0% (P\u2009&amp;lt;\u2009.001) and from 54.1% to 43.2% (P\u2009&amp;lt;\u2009.001), respectively. The percentage of infants with a PCT increased from 3.9% to 94.1% post-implementation (P\u2009&amp;lt;\u2009.001). The 30-day readmission rate was 3.5% in the pre-implementation and 4.8% in the post-implementation period (P\u2009=\u2009.26).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Incorporation of the modified PECARN prediction rule to an existing febrile infant care process model resulted in decreased lumbar punctures and hospital admissions without significantly increasing 30-day readmissions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpids\/piag087","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:57:24Z","timestamp":1788289044000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes after Modified Pediatric Emergency Care Applied Research Network Procalcitonin Rule Implementation in Febrile Infant Care Process Model"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-9614","authenticated-orcid":false,"given":"Jared","family":"Olson","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]},{"name":"Department of Pharmacy, Primary Children\u2019s Hospital , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cipriano","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hospitalist Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Jridi","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, The University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni D","family":"Lane","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per H","family":"Gesteland","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hospitalist Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Hersh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Intermountain Health, Intermountain Children's Health , Murray, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Valentine","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Neil","family":"Davis","sequence":"additional","affiliation":[{"name":"Intermountain Health, Intermountain Children's Health , Murray, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Schunk","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A","family":"Thorell","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah , Salt Lake City, UT ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026091610363874300_ref1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.idc.2015.05.008","article-title":"Evaluation and management of febrile, well-appearing young infants","volume":"29","author":"Biondi","year":"2015","journal-title":"Infect Dis Clin N Am"},{"key":"2026091610363874300_ref2","doi-asserted-by":"publisher","first-page":"e2021052228","DOI":"10.1542\/peds.2021-052228","article-title":"Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 days old","volume":"148","author":"Pantell","year":"2021","journal-title":"Pediatrics."},{"key":"2026091610363874300_ref3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamapediatrics.2018.5501","article-title":"Febrile infant working Group of the Pediatric Emergency Care Applied Research Network (PECARN). A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections","volume":"173","author":"Kuppermann","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2026091610363874300_ref4","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1542\/peds.2012-0127","article-title":"Costs and infant outcomes after implementation of a care process model for febrile infants","volume":"130","author":"Byington","year":"2012","journal-title":"Pediatrics."},{"key":"2026091610363874300_ref5","doi-asserted-by":"publisher","first-page":"e172927","DOI":"10.1001\/jamapediatrics.2017.2927","article-title":"Febrile infant working Group of the Pediatric Emergency Care Applied Research Network. Accuracy of complete blood cell counts to identify febrile infants 60 days or younger with invasive bacterial infections","volume":"171","author":"Cruz","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2026091610363874300_ref6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1542\/hpeds.2017-0254","article-title":"The prevalence of bacterial meningitis in febrile infants 29-60 days with positive urinalysis","volume":"8","author":"Young","year":"2018","journal-title":"Hosp Pediatr"},{"key":"2026091610363874300_ref7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/PEC.0000000000002905","article-title":"Impact on emergency department interventions after implementing a guideline based on the Pediatric emergency care applied research network prediction rule for identifying low-risk febrile infants 29 to 60 days old","volume":"39","author":"Mukherjee","year":"2023","journal-title":"Pediatr Emerg Care"},{"key":"2026091610363874300_ref8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4094\/chnr.2025.013","article-title":"The changing landscape of pediatric infectious diseases before, during, and after the COVID-19 pandemic","volume":"31","author":"Eun","year":"2025","journal-title":"Child Health Nurs Res"},{"key":"2026091610363874300_ref9","doi-asserted-by":"publisher","first-page":"e2023063339","DOI":"10.1542\/peds.2023-063339","article-title":"AAP REVISE II QI collaborative improving guideline-concordant Care for Febrile Infants through a quality improvement initiative","volume":"153","author":"McDaniel","year":"2024","journal-title":"Pediatrics."},{"key":"2026091610363874300_ref10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1542\/hpeds.2020-000380","article-title":"Use of procalcitonin in a febrile infant clinical pathway and impact on infants aged 29 to 60 days","volume":"11","author":"Widmer","year":"2021","journal-title":"Hosp Pediatr"},{"key":"2026091610363874300_ref11","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1542\/hpeds.2024-007906","article-title":"Procalcitonin use after clinical practice guideline and QI intervention for febrile infants","volume":"14","author":"Shine","year":"2024","journal-title":"Hosp Pediatr."},{"key":"2026091610363874300_ref12","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1097\/pq9.0000000000000616","article-title":"Boston febrile infant algorithm 2.0: improving Care of the Febrile Infant 1-2 months of age","volume":"7","author":"Dorney","year":"2022","journal-title":"Pediatr Qual Saf"},{"key":"2026091610363874300_ref13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2025.21454","article-title":"Prediction of Bacteremia and bacterial meningitis among febrile infants aged 28 days or younger","volume":"335","author":"Burstein","year":"2025","journal-title":"JAMA."},{"key":"2026091610363874300_ref14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpeds.2016.02.015","article-title":"Initial presentation of neonatal herpes simplex virus infection","volume":"172","author":"Curfman","year":"2016","journal-title":"J Pediatr"},{"key":"2026091610363874300_ref15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/diagnostics11050846","article-title":"Blood procalcitonin level as a diagnostic marker of Pediatric bacterial meningitis: a systematic review and meta-analysis","volume":"11","author":"Kim","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2026091610363874300_ref16","doi-asserted-by":"publisher","first-page":"e015700","DOI":"10.1136\/bmjopen-2016-015700","article-title":"Assessment of healthcare delivery in the early management of bacterial meningitis in UK young infants: an observational study","volume":"7","author":"Okike","year":"2017","journal-title":"BMJ Open"},{"key":"2026091610363874300_ref17","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1007\/s11606-025-09520-8","article-title":"Communicating numeric risk information to patients","volume":"40","author":"Peters","year":"2025","journal-title":"J Gen Intern Med"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piag087\/70895810\/piag087.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/15\/9\/piag087\/70895810\/piag087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/15\/9\/piag087\/70895810\/piag087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:36:51Z","timestamp":1789569411000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piag087\/8778733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,14]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piag087","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"piag087"}}